Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

Overview of attention for article published in European Urology, January 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

blogs: 1 blog
twitter: 14 X users

f1000: 1 research highlight platform
guideline: 3 clinical guideline sources

Readers on

mendeley: 341 Mendeley

So far, Altmetric has seen 16 X posts from 14 X users, with an upper bound of 69,515 followers.

@SteinhausAndrew @radiolobt @Dr_RaviMadan @samsimsal @smkaff @MDxHealth Neg MRI v. reassuring and correct re: scant data, but best data is here: https://t.co/ZW6BxpWtYq Yes to annual PSA, lower biopsy threshold

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening ro... http://t.co/Ow8Dm1KHe0

"Germ line #genetic markers can be used to identify men at higher #risk of #prostate #cancer" http://t.co/Qa0OqkRXoT #targeted #screening

Latest research supports the use of PSA screening for BRCA2 carriers – results from the IMPACT study. http://t.co/ld2TdCY57K

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 12 additional X posts.